Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT04398394
Eligibility Criteria:
Inclusion Criteria:
Group 1
* Individuals, 18 to 50 yo, with normal eye fundus.
* Emmetropic or ametropic between +3D and -3D
Group 2
* Individuals, 18 to 50 yo, with normal eye fundus.
* Myopic between -6D and -12D.
Group 3
* Individuals over the age of 50 and age-matched to patients with AMD.
* With nwith normal eye fundus.
* Astigmatic, myopic (\<-12D) or presbyopic participants may be included
Group 4
* Patient over 50 yo, with early or intermediate AMD, including extrafoveolar geographic atrophy
* with visual acuity ≥ 0.6 and clinical judgment of good central fixation.
Group 5
* Patient over 18, with other retinopathy than AMD,
* with visual acuity ≥ 0.6 and nd clinical judgment of good fixation
Exclusion Criteria:
Eye with
* RPE detachment
* a clinically unclear situation
* abnormality preventing good visualization of the fundus
* less than 3 months post-surgery of the anterior segment
* less than 6 months post-surgery of the posterior segment
* active uveitis - myopia ≥12D, hyperopia \> +5D, astigmatism \> 4D
* contraindication to dilatation
* a palpebral opening that is less than 6 mm in height
Individual:
* albino - unable to fix a target at least 10 seconds
* who does not tolerate being in the dark for 30 minutes
* unable to follow the procedures of the study
* refusing to be informed of the incidental discovery of a clinically significant pathology Investigators of the study, their family members, collaborators and students
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04398394
Study Brief:
Protocol Section:
NCT04398394